Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$25,823,360
+$1,993,911 QoQ
Shares Held
200,960
+1.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.09%
of 13F equity value
Holder Rank
#462
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAYDEN & RYGEL holds $102,478,534 across 7 Drug Manufacturers - General names. MRK ranks #1 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
200,960 | $25,823,360 | |
| 2 | ABBV |
AbbVie Inc.
|
73,250 | $18,432,630 | |
| 3 | LLY |
ELI LILLY & Co
|
14,670 | $17,595,639 | |
| 4 | JNJ |
Johnson & Johnson
|
64,900 | $16,482,653 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
126,560 | $15,989,590 | |
| 6 | PFE |
Pfizer Inc
|
311,580 | $7,502,846 | |
| 7 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,823,360 | 200,960 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $23,829,449 | 198,100 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $20,852,006 | 198,100 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $16,610,586 | 197,910 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $293,683 | 3,710 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $665,121 | 7,410 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,096,994 | 111,550 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,025,634 | 185,150 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $14,874,570 | 120,150 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $17,384,412 | 131,750 | Shares | Sole | 2024-10-08 | |
| 2023-12-31 | $18,189,987 | 166,850 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $17,177,207 | 166,850 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $22,610,670 | 195,950 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $25,512,322 | 239,800 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $37,502,209 | 338,010 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,810,565 | 404,210 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $17,086,169 | 187,410 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $279,790 | 3,410 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $261,342 | 3,410 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $36,091,106 | 480,510 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $32,788,609 | 421,610 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $32,671,530 | 423,810 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $24,270,867 | 296,710 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $36,399,306 | 438,810 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $32,432,989 | 419,410 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $43,432,611 | 564,500 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||